Daniel M. Bendheim, Executive VP, Corporate Strategy at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 7,681 shares at $40.08 ($308K) on 2017-08-14, disclosed to the SEC on 2017-08-16.
Open-market sale of $308k PAHC by Executive VP, Corporate Strategy. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.08 | 300 | $12K | 3.9% |
| 2 | $40.05 | 1,443 | $58K | 18.8% |
| 3 | $40.04 | 5,938 | $238K | 77.3% |
| Total | $40.04 avg | 7,681 | $308K | 100% |
| Filing → |
| PAHC | SELL | 2019-01-18 | $242K | — | Filing → |
| PAHC | SELL | 2019-01-10 | $162K | — | Filing → |
| PAHC | SELL | 2019-01-07 | $238K | — | Filing → |